{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:11:29Z","timestamp":1789398689122,"version":"build-2803163510"},"reference-count":32,"publisher":"PAGEPress Publications","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Ital Urol Androl"],"abstract":"<jats:p>Background\/Objectives: Bladder cancer is a multifactorial disease, ranking as the 10th most common cancer globally and the fourth most common cancer in men and the ninth in women in the Western world. This bibliometric analysis aims to identify and evaluate scientific literature addressing new biomarkers for bladder cancer diagnosis, as well as to identify the most prolific organizations, authors, journals, countries, and keywords within this research domain.Methods: An electronic search was conducted using Elsevier's Scopus database. From a total of 940 retrieved papers (published between 2019 and 2024), 493 were selected. For data analysis and visualization, the titles of articles, year of publication, countries, authors, journals, articles, and keywords were analyzed using Microsoft Excel, VOSviewer, and Biblioshiny. Results: China published the most papers (200 articles) and received the highest number of citations, followed by the USA. While some countries, such as Egypt and India, published exclusively Single Country Publications (SCPs), others demonstrated a higher level of international collaboration, with at least half of their publications being Multi-Country Publications (MCPs). Countries with higher rates of MCPs were Greece (66.6%), Italy (53.8%), Korea, and France (50%). The journals that produced the most publications and received the highest number of citations were Cancers, International Journal of Molecular Sciences, and Frontiers in Oncology, confirming their role in producing high-impact research. Conclusions: The consistent distribution of publications over the years considered indicates a sustained interest in this field.<\/jats:p>","DOI":"10.4081\/aiua.2025.13396","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T09:00:45Z","timestamp":1739264445000},"source":"Crossref","is-referenced-by-count":2,"title":["New biomarkers for diagnosis of bladder cancer: a bibliometric analysis"],"prefix":"10.4081","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6247-7037","authenticated-orcid":false,"given":"Roberto","family":"Falabella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4315-7660","authenticated-orcid":false,"given":"Felice","family":"Crocetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3865-5988","authenticated-orcid":false,"given":"Francesco","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0464-0788","authenticated-orcid":false,"given":"Nazario","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-132X","authenticated-orcid":false,"given":"Biagio","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0564-7415","authenticated-orcid":false,"given":"Luca","family":"Di Gianfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Di Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9462-1427","authenticated-orcid":false,"given":"Vincenzo Francesco","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2549","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"165434","doi-asserted-by":"crossref","unstructured":"Karam JA, Lotan Y, Shariat SF. Urine cytology and commercially available urine-based markers for monitoring of bladder urothelial carcinoma. Lab Med. 2007; 38:48-52.","DOI":"10.1309\/DTJXKUDMQ49P80LR"},{"key":"165435","doi-asserted-by":"crossref","unstructured":"Feil G, Stenzl A. Tumor marker tests in bladder cancer. Actas Urol Esp. 2006; 30:38-45.","DOI":"10.1016\/S0210-4806(06)73394-0"},{"key":"165436","doi-asserted-by":"crossref","unstructured":"Mitropoulos D, Adamakis I, Perimenis P. Contemporary diagnosis of bladder cancer. Expert Opin Med Diagn. 2008; 2:713-20.","DOI":"10.1517\/17530059.2.6.713"},{"key":"165437","doi-asserted-by":"crossref","unstructured":"Lopez-Beltran A, Cheng L, Gevaert T, et al. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Expert Rev Mol Diagn. 2020; 20:231-43.","DOI":"10.1080\/14737159.2020.1699791"},{"key":"165438","doi-asserted-by":"crossref","unstructured":"Linscott JA, Miyagi H, Murthy PB, et al. From Detection to cure - emerging roles for urinary tumor DNA (utDNA) in bladder cancer. Curr Oncol Rep. 2024; 26:945-58.","DOI":"10.1007\/s11912-024-01555-0"},{"key":"165439","doi-asserted-by":"crossref","unstructured":"Lee HH, Kim SH. Review of non-invasive urinary biomarkers in bladder cancer. Transl Cancer Res. 2020; 9:6554-64.","DOI":"10.21037\/tcr-20-1990"},{"key":"165440","doi-asserted-by":"crossref","unstructured":"Jordaens S, Oeyen E, Willems H, et al. Protein biomarker discovery studies on urinary sEV fractions separated with UF-SEC for the first diagnosis and detection of recurrence in bladder cancer patients. Biomolecules. 2023; 13:932.","DOI":"10.3390\/biom13060932"},{"key":"165441","doi-asserted-by":"crossref","unstructured":"Satam H, Joshi K, Mangrolia U, et al. Next-generation sequencing technology: current trends and advancements. Biology. 2023;12:997.","DOI":"10.3390\/biology12070997"},{"key":"165442","doi-asserted-by":"crossref","unstructured":"Gogalic S, Sauer U, Doppler S, et al. Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer. Biomarkers. 2017; 1-8.","DOI":"10.1080\/1354750X.2016.1276628"},{"key":"165443","doi-asserted-by":"crossref","unstructured":"Tan WS, Tan WP, Tan MY, et al. Novel urinary biomarkers for the detection of bladder cancer: A systematic review. Cancer Treat Rev. 2018; 69:39-52.","DOI":"10.1016\/j.ctrv.2018.05.012"},{"key":"165444","doi-asserted-by":"crossref","unstructured":"Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: How great is the impact? Scientometrics 2015;105:1809-31.","DOI":"10.1007\/s11192-015-1645-z"},{"key":"165445","doi-asserted-by":"crossref","unstructured":"Hossain MM. Current status of global research on novel coronavirus disease (COVID-19): a bibliometric analysis and knowledge mapping. F1000Research. 2020; 9:374.","DOI":"10.12688\/f1000research.23690.1"},{"key":"165446","doi-asserted-by":"crossref","unstructured":"Chahrour M, Assi S, Bejjani M, et al. A bibliometric analysis of COVID-19 research activity: a call for increased output. Cureus 2020;12:e7357.","DOI":"10.7759\/cureus.7357"},{"key":"165447","doi-asserted-by":"crossref","unstructured":"Kelly JC, Glynn RW, O\u2019Briain DE, et al. The 100 classic papers of orthopaedic surgery: a bibliometric analysis. J Bone Joint Surg Br. 2010; 92-B:1338-43.","DOI":"10.1302\/0301-620X.92B10.24867"},{"key":"165448","doi-asserted-by":"crossref","unstructured":"Vaishya R, Gopinathan P, Gupta BM, et al. Scholarly trends in global orthopedics research published through the Journal of Orthopaedics: A bibliometric analysis from 2013 to 2024. J Orthop. 2025; 60:35-43.","DOI":"10.1016\/j.jor.2024.08.013"},{"key":"165449","doi-asserted-by":"crossref","unstructured":"Zhang Y, Xiao F, Lu S, et al. Research trends and perspectives of male infertility: a bibliometric analysis of 20 years of scientific literature. Andrology. 2016; 4:990-1001.","DOI":"10.1111\/andr.12204"},{"key":"165450","doi-asserted-by":"crossref","unstructured":"Akbari R, Hantoushzadeh S, Panahi Z, et al. A bibliometric review of 35 years of studies about preeclampsia. Front Physiol. 2023; 14:1110399.","DOI":"10.3389\/fphys.2023.1110399"},{"key":"165451","doi-asserted-by":"crossref","unstructured":"Alam BF, Nayab T, Ali S, et al. Current scientific research trends on salivary biomarkers: a bibliometric analysis. Diagnostics. 2022;12:1171.","DOI":"10.3390\/diagnostics12051171"},{"key":"165452","doi-asserted-by":"crossref","unstructured":"Wu CC, Islam MdM, Poly TN, Weng YC. Artificial intelligence in kidney disease: a comprehensive study and directions for future research. Diagnostics. 2024; 14:397.","DOI":"10.3390\/diagnostics14040397"},{"key":"165453","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg. 2010; 8:336-41.","DOI":"10.1016\/j.ijsu.2010.02.007"},{"key":"165454","doi-asserted-by":"crossref","unstructured":"Aria M, Cuccurullo C. bibliometrix: An R-tool for comprehensive science mapping analysis. J Informetr. 2017; 11:959-75.","DOI":"10.1016\/j.joi.2017.08.007"},{"key":"165455","doi-asserted-by":"crossref","unstructured":"Han J, Kang HJ, Kim M, Kwon GH. Mapping the intellectual structure of research on surgery with mixed reality: bibliometric network analysis (2000-2019). J Biomed Inform. 2020; 109:103516.","DOI":"10.1016\/j.jbi.2020.103516"},{"key":"165456","doi-asserted-by":"crossref","unstructured":"Alix-Panabi\u00e8res C, Pantel K. Liquid biopsy: from discovery to clinical application. Cancer Discov. 2021; 11:858-73.","DOI":"10.1158\/2159-8290.CD-20-1311"},{"key":"165457","doi-asserted-by":"crossref","unstructured":"Usuba W, Urabe F, Yamamoto Y, et al. Circulating miRNA panels for specific and early detection in bladder cancer. Cancer Sci. 2019; 110:408-19.","DOI":"10.1111\/cas.13856"},{"key":"165458","doi-asserted-by":"crossref","unstructured":"Chen X, Zhang J, Ruan W, et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Invest. 2020; 130:6278-89.","DOI":"10.1172\/JCI139597"},{"key":"165459","doi-asserted-by":"crossref","unstructured":"Zhang S, Du L, Wang L, et al. Evaluation of serum exosomal Lnc RNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer. J Cell Mol Med. 2019; 23:1396-405.","DOI":"10.1111\/jcmm.14042"},{"key":"165460","doi-asserted-by":"crossref","unstructured":"Fest J, Ruiter R, Mulder M, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer\u2014A population-based cohort study. Int J Cancer. 2020;146:692-8.","DOI":"10.1002\/ijc.32303"},{"key":"165461","doi-asserted-by":"crossref","unstructured":"Huang J, Jiang Y, Li J, et al. A renal-clearable macromolecular reporter for near-infrared fluorescence imaging of bladder cancer. Angew Chem Int Ed. 2020; 59:4415-20.","DOI":"10.1002\/anie.201911859"},{"key":"165462","doi-asserted-by":"crossref","unstructured":"Mi X, Zou B, Zou F, Hu J. Permutation-based identification of important biomarkers for complex diseases via machine learning models. Nat Commun. 2021; 12:3008.","DOI":"10.1038\/s41467-021-22756-2"},{"key":"165463","doi-asserted-by":"crossref","unstructured":"Wang Y, Li Z, Lin Q, et al. Highly sensitive detection of bladder cancer-related miRNA in urine using time-gated luminescent biochip. ACS Sens. 2019; 4:2124-30.","DOI":"10.1021\/acssensors.9b00927"},{"key":"165464","doi-asserted-by":"crossref","unstructured":"Yu C, Longfei L, Long W, et al. LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells. J Cell Physiol. 2019; 234:1346-53.","DOI":"10.1002\/jcp.26929"},{"key":"165465","doi-asserted-by":"crossref","unstructured":"Laukhtina E, Shim SR, Mori K, et al. Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis. Eur Urol Oncol. 2021; 4:927-42.","DOI":"10.1016\/j.euo.2021.10.003"}],"container-title":["Archivio Italiano di Urologia e Andrologia"],"original-title":[],"link":[{"URL":"https:\/\/www.pagepressjournals.org\/aiua\/article\/download\/13396\/12825","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepressjournals.org\/aiua\/article\/download\/13396\/12825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T09:01:09Z","timestamp":1739264469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pagepressjournals.org\/aiua\/article\/view\/13396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":32,"URL":"https:\/\/doi.org\/10.4081\/aiua.2025.13396","relation":{},"ISSN":["2282-4197","1124-3562"],"issn-type":[{"value":"2282-4197","type":"electronic"},{"value":"1124-3562","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,11]]}}}